Depression
Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
RecruitingNCT04123314
About this title
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Read the official source — NCT04123314Official study titlePilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease
In BaltimoreDepressionMedication studyAges 18–85
- Countries
- United States
- Sponsor
- Johns Hopkins University
RecruitingNCT07241325
Official study titleA Cross-Sectional Observational Study to Evaluate Psychological Well-Being, Depression, and Health-Related Quality of Life and Their Demographic and Clinical Correlates in Adults With Type 2 Diabetes Attending an Outpatient Metabolic Clinic
In TaipeiDepressionObservational studyAges 18+
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
RecruitingNCT07554326
What is this study about?This study assesses depression symptoms.
In ChicagoDepressionBehavioural studyAges 15–20
- Countries
- United States
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
RecruitingNCT06070766
About this title
RIVER At Home Ketamine Protocols
Read the official source — NCT06070766Official study titleCan Digital Health Technology Guide Medical Providers, in Treating Chronic Conditions With RIVER Ketamine Protocols Safely at Home?
Multiple locations, including BigforkDepression, PTSD, ...Observational studyAges 18+
- Countries
- United States
- Sponsor
- RIVER Foundation
RecruitingNCT07652775
Official study titleEffects of Repetitive Transcranial Magnetic Stimulation Combined With Aerobic Exercise on Cognitive Function, Psychological Health, and Walking Performance in Older Adults With Mild Cognitive Impairment and Comorbid Depression: A Randomized Controlled Trial
In TaipeiDepressionDevice studyAges 65–90
- Countries
- Taiwan
- Sponsor
- Cheng-Hsin General Hospital
RecruitingNCT07140575
About this title
rTMS for Youth Inpatients With Depression
Read the official source — NCT07140575Official study titleSeamless Integration of Repetitive Transcranial Magnetic Stimulation (rTMS) for Youth Inpatients With Depression: A Feasibility Study
In TorontoDepressionDevice studyAges 14–19
- Countries
- Canada
- Sponsor
- Sunnybrook Health Sciences Centre
RecruitingNCT06824415
About this title
Sleep TMS for Depression
Read the official source — NCT06824415Official study titleOptimizing Depression Treatment Through Sleep-state Brain Stimulation
In StanfordDepressionDevice studyAges 18–65
- Countries
- United States
- Sponsor
- Stanford University
RecruitingNCT06671977
About this title
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
Read the official source — NCT06671977Official study titlePhase 1 Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
In West HavenDepressionMedication studyAges 21–65
- Countries
- United States
- Sponsor
- Deepak C. D'Souza
RecruitingNCT07560878
In BelmontDepressionMedication studyAges 18+
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)
RecruitingNCT07593222
In BelmontDepressionMedication studyAges 18+
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)
RecruitingNCT06187454
About this title
Transcranial Direct Current Stimulation for Depression
Read the official source — NCT06187454Official study titleTranscranial Direct Current Stimulation for Depression
In TaipeiDepressionDevice studyAges 60+
- Countries
- Taiwan
- Sponsor
- Taipei Veterans General Hospital, Taiwan
RecruitingNCT06364488
About this title
TrueBlue Clinical Study - Investigating the Use of a Mobile Phone App TrueBlue for Monitoring Depression and Anxiety
Read the official source — NCT06364488Official study titleTrueBlue Clinical Study - Investigating the Use of a Mobile Phone App TrueBlue for Monitoring Depression and Anxiety
In NottinghamDepression, AnxietyDevice studyAges 18+
- Countries
- United Kingdom
- Sponsor
- BlueSkeye AI